- CEO
- Geun-Yong Lee
- Full Time Employees
- 114
- Sector
- Health technology
- Industry
- Medical specialties
- Address
- Cheongju-si South Korea
- IPO Date
- Aug 14, 2018
- Business
- REMED Co., Ltd. is a South Korea-based medical device company that specializes in the research, development, manufacturing, and commercialization of non-invasive electromagnetic and acoustic stimulation systems for neurology, pain management, and medical aesthetics. Founded in 2003 and headquartered in Seongnam-si, Gyeonggi-do, South Korea, the company operates across three primary business segments: Neuromodulation (Brain Stimulation), Neuromuscular Stimulation (Pain Management), and Medical Aesthetics.
The company offers a comprehensive portfolio of medical and aesthetic equipment comprising: Transcranial Magnetic Stimulation (TMS) systems, including the ALTMS, BrainStim, and TAMAS series, which deliver non-invasive repetitive magnetic pulses to stimulate cortical neurons for the clinical treatment of major depressive disorder, stroke rehabilitation, Parkinson's disease, and psychiatric disorders; TMS navigation systems and localized coil apparatuses for precision brain mapping; Neuromuscular Stimulation (NMS) devices, including the Talent-A, Talent-Pro, Salus-Talent, Salus-Talent Pro, and Optimus-Pro systems, which utilize pulsed magnetic fields to stimulate deep motor nerves and muscles for chronic musculoskeletal pain relief and physical rehabilitation; Extracorporeal Shock Wave Therapy (ESWT) devices, encompassing radial and focused shockwave units for orthopedic therapy and soft tissue repair; and Aesthetic and Body Contouring systems, including the PERFECT, Tone-A, CoolFMS, and UI-Talent lines, designed for high-intensity electromagnetic muscle strengthening, body sculpting, and pelvic floor muscle stimulation for urinary incontinence treatment. In addition, REMED provides original equipment manufacturing (OEM) and original design manufacturing (ODM) solutions, supplying specialized electromagnetic power modules and therapeutic subsystems to multinational healthcare corporations.
REMED distributes its products to hospitals, psychiatric facilities, rehabilitation clinics, orthopedic centers, dermatology practices, and aesthetic medical spas across domestic and international markets, including North America, Europe, Asia-Pacific, and Latin America, utilizing a global network of distributors alongside strategic partnerships with medical technology corporations such as Zimmer MedizinSysteme and Allergan Aesthetics. In recent operational and strategic developments, REMED has expanded its global commercial footprint by securing regulatory clearances, including European Medical Device Regulation (CE MDR) certifications and U.S. Food and Drug Administration (FDA) 510(k) clearances for its next-generation TMS and NMS systems; expanded OEM supply agreements for magnetic body contouring and pain therapy hardware; broadened clinical research and multi-center trials targeting expanded neurological indications such as dementia, sleep disorders, and pediatric developmental conditions; and introduced portable neuromodulation devices and AI-integrated navigation solutions to enhance therapeutic targeting and support decentralized care.